Tuberculous peritonitis in a haemodialysis patient with elevated serum CA 125 and hypercalcaemia

I. K. Wang, F. R. Chuang, K. F. Lee, C. L. Lin, H. Y. Chang, Chih Kun Huang*

*此作品的通信作者

研究成果: 期刊稿件文章同行評審

5 引文 斯高帕斯(Scopus)

摘要

CA 125, a glycoprotein derived from coelomic epithelium, is used primarily as a marker of epithelial ovarian cancer. However, elevated levels of serum CA 125 have also been detected in other benign and malignant disorders. This study describes a haemodialysis patient who contracted tuberculous peritonitis associated with hypercalcaemia, erythropoietin-resistant anaemia and elevated CA 125, which normalised gradually following antituberculosis treatment. Tuberculous peritonitis should be considered in the differential diagnosis of ascites with elevated serum CA 125. Additionally, CA 125 is a useful marker for monitoring response to tuberculous peritonitis treatment.

原文英語
頁(從 - 到)56-59
頁數4
期刊International Journal of Clinical Practice
59
發行號SUPPL. 147
DOIs
出版狀態已出版 - 04 2005
對外發佈

指紋

深入研究「Tuberculous peritonitis in a haemodialysis patient with elevated serum CA 125 and hypercalcaemia」主題。共同形成了獨特的指紋。

引用此